PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1514949
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1514949
Biomanufacturing Viral Detection and Quantification Market size was valued at USD 492.2 Million in 2023, expanding at a CAGR of 8.00% from 2024 to 2032.
The global biomanufacturing viral detection and quantification market includes the products, services, and technology used to detect and quantify viral contamination during biopharmaceutical manufacturing processes. It encompasses a wide range of methods, including polymerase chain reaction (PCR), immunoassays, sequencing, and other molecular techniques designed to identify and quantify viruses at various stages of biopharmaceutical production, such as cell line development, upstream and downstream processing, and product testing.
Biomanufacturing Viral Detection and Quantification Market- Market Dynamics
Increasing Utilization of Biopharmaceuticals
The growing use of single-cell analysis in viral detection technologies in the viral detection and quantification market will drive up demand for viral detection. Single-cell analysis is the study of individual cells or very tiny groups of cells. Viral detection technologies, such as single-molecule localization microscopy, aid in the study of single cells, hence driving the market. This development underscores the requirement to assure excellent product quality and safety by preventing virus contamination throughout the manufacturing process. It's no surprise that the increased use of biopharmaceuticals necessitates better and more powerful virus detection approaches to ensure the quality of such valuable treatments.
Biomanufacturing Viral Detection and Quantification Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.00% over the forecast period (2024-2032)
Based on Offering Type segmentation, in 2023, the consumables category conquered the global biomanufacturing viral detection and quantification market.
Based on Technology segmentation, in 2023, the PCR segment led the market.
Based on Application segmentation, the blood and blood products manufacturing segment was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
The Global Biomanufacturing Viral Detection and Quantification Market is segmented on the basis of Technology, Offering Type, Application, End User, and Region.
The market is divided into three categories based on Offering Type: Consumables, Instruments, and Services. In 2023, the consumables category dominated the worldwide biomanufacturing viral detection and quantification market. The growing popularity of kits, tests, and accessories has helped to elevate the consumables market. Consumables are products and ingredients that are used continuously during the viral testing process. Numerous consumables are used in viral detection and quantification throughout biomanufacturing to make testing and analysis of viral samples easier. These consumables are required to carry out the many processes and tests needed to detect the amount or concentration of a certain virus in a biological sample.
The market is divided into five categories based on Technology: ELISA, PCR, Flow Cytometry, Plaque Assay, and Others. In 2023, the PCR segment led the worldwide biomanufacturing market for viral detection and quantification. Polymerase chain reaction (PCR) is a widely used technique in molecular biology and virus testing. It is a sensitive and targeted method for recognizing and measuring viral nucleic acids utilized in biopharmaceutical manufacture. Furthermore, PCR is required for determining the viral load, or quantity of viral genetic material, in a biological specimen.
Biomanufacturing Viral Detection and Quantification Market- Geographical Insights
Geographically, this market is prevalent in North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. These regions are further segmented according to the countries bringing commerce. North America dominates the worldwide biomanufacturing viral detection and quantification market due to the proliferation of big PCR test product manufacturers, the presence of important market participants, and increased technical improvement in the region.
Asia-Pacific is predicted to grow at the fastest CAGR during the forecast period 2024-2032, owing to ongoing research and development in the viral detection and quantification market, as well as a favorable regulatory environment.
The competitive landscape in the Biomanufacturing Viral Detection and Quantification Market is ever-changing, driven by the demand for novel technologies to identify and quantify viruses in biopharmaceutical production. Key market participants include Thermo Fisher Scientific Inc., Merck KGaA, Sartorius AG, Charles River Laboratories, and Danaher Corporation. These companies concentrate on creating advanced detection methods to fulfill the growing demands of the biopharmaceutical industry. Competition is severe as firms compete to provide dependable and effective viral detection systems that ensure the quality and safety of biopharmaceutical goods.
In September 2021, Thermo Fisher Scientific announced the signing of a definitive deal with Becton, Dickinson, and Company (BDX) to buy their Advanced Bioprocessing division. This BD company generated around $100 million in yearly revenue and was incorporated into Thermo Fisher's Life Sciences Solutions Segment on October 16, 2021.
GLOBAL BIOMANUFACTURING VIRAL DETECTION AND QUANTIFICATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Thermo Fisher Scientific Inc. (U.S.)
Merck KGaA (Germany)
Sartorius AG (Germany)
Charles River Laboratories (U.S.)
Danaher Corporation (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
QIAGEN (Netherlands)
Lonza Group Ltd. (Switzerland)
Pall Corporation (U.S.)
PerkinElmer, Inc. (U.S.)
GE Healthcare (U.S.)
Roche Diagnostics International Ltd. (Switzerland)
BD (U.S.), Promega Corporation (U.S.)
FUJIFILM Diosynth Biotechnologies (U.S.)
Avantor, Inc. (U.S.)
SGS Societe Generale de Surveillance SA. (Switzerland)
Eurofins Scientific (Luxembourg)
Virapur LLC (U.S.)
BioReliance Corporation (U.S.)
Others